ENT Liu Knowledge Base Head & neck tumours · physician reviewed
Salivary Gland Tumours · Prevention & risk

Can salivary gland tumours be prevented?

Reviewed: 8 November 2026 By: Xiangpeng Liu, MD Topic: Salivary Gland Tumours Answer length: short, citable
Quick answer

Many cases are preventable. The most useful steps for salivary gland tumours are avoid unnecessary head and neck radiation, especially in children, stop smoking — relevant to Warthin tumour and overall head and neck cancer risk and use respiratory protection in dust- and nickel-exposed occupations. Prevention works best before exposure begins, but stopping tobacco, areca nut and heavy alcohol use still lowers risk after many years of use.

In detail

There is no population screening programme for most head and neck cancers. A routine oral examination by a dentist or doctor, plus early assessment of persistent symptoms, is currently the most practical early-detection strategy for patients outside high-risk screening programmes.

  • Avoid unnecessary head and neck radiation, especially in children
  • Stop smoking — relevant to Warthin tumour and overall head and neck cancer risk
  • Use respiratory protection in dust- and nickel-exposed occupations
  • Have any persistent parotid or submandibular lump imaged and sampled rather than observed indefinitely
  • Long-term follow-up after pleomorphic adenoma to detect rare malignant transformation

What this means in practice: this answer is part of the “Prevention & risk” section of the Salivary Gland Tumours topic. If you are comparing treatment options, also read how to compare a second opinion and which records to send.

Other common questions about salivary gland tumours

See all 14 questions in this topic →

Sources for this answer

  1. IARC Monographs on the Identification of Carcinogenic Hazards to Humans (tobacco, areca nut, UV radiation, EBV, HPV) International Agency for Research on Cancer / WHO · 2024
  2. Global incidence of lip, oral cavity, and pharyngeal cancers by subsite in 2022 CA: A Cancer Journal for Clinicians · 2026 · Subsite-level estimates for 185 countries; the basis of the regional atlas on this site.
  3. Global Cancer Observatory (GLOBOCAN 2022) International Agency for Research on Cancer / WHO · 2022 · Source of worldwide and country-level incidence and mortality estimates.
  4. Nivolumab Risk Management Plan — epidemiological characteristics of SCCHN (GLOBOCAN 2022 summary) European Medicines Agency · 2025 · Reports the combined 947,211 head and neck cancer cases in 2022 and regional ASRs.
  5. NCCN Guidelines for Patients: Head and Neck Cancers National Comprehensive Cancer Network · 2025

Written and medically reviewed by Xiangpeng Liu, MD

Associate Chief Physician, ENT & Head/Neck Surgery · Chenzhou First People’s Hospital, Chenzhou, Hunan, China

Editorial policy & reviewer credentials · All sources

← Previous questionWhat is the prognosis for salivary gland tumours? Next question →Is a parotid lump usually cancer?

Need an opinion on your own case?

International patients can request a preliminary review based on pathology and imaging before travelling to China.

How the pathway works Send an enquiry

Medical disclaimer: This knowledge base is general information for people researching head and neck tumours, not a diagnosis or treatment plan. It does not replace an examination by a qualified physician. Survival figures are population averages, not predictions for an individual. Treatment and cost estimates for China are illustrative only and must be confirmed in writing after your records have been reviewed. If you have a symptom lasting more than two to three weeks, see a doctor promptly.